BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19767778)

  • 1. Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan.
    Kudo K; Ohga S; Morimoto A; Ishida Y; Suzuki N; Hasegawa D; Nagatoshi Y; Kato S; Ishii E
    Bone Marrow Transplant; 2010 May; 45(5):901-6. PubMed ID: 19767778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning.
    Steiner M; Matthes-Martin S; Attarbaschi A; Minkov M; Grois N; Unger E; Holter W; Vormoor J; Wawer A; Ouachee M; Woessmann W; Gadner H
    Bone Marrow Transplant; 2005 Aug; 36(3):215-25. PubMed ID: 15937510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of refractory Langerhans cell histiocytosis with pulmonary aspergillosis by reduced-intensity conditioning cord blood transplantation.
    Hatakeyama N; Hori T; Yamamoto M; Inazawa N; Hirako Y; Tsutsumi H; Suzuki N
    Pediatr Transplant; 2010 May; 14(3):E4-10. PubMed ID: 19175514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis.
    Cooper N; Rao K; Goulden N; Webb D; Amrolia P; Veys P
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S47-50. PubMed ID: 18978744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
    Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
    Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan.
    Kinugawa N; Imashuku S; Hirota Y; Yamada K; Yamamoto A; Akazai A; Oda M; Miura N; Kakuta H; Sato T; Endo M; Takano T
    Bone Marrow Transplant; 1999 Oct; 24(8):935-8. PubMed ID: 10516710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation in Langerhans cell histiocytosis: case report and review of the literature.
    Kesik V; Citak C; Kismet E; Koseoglu V; Akyuz C
    Pediatr Transplant; 2009 May; 13(3):371-4. PubMed ID: 18518907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
    Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M
    J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group.
    Akkari V; Donadieu J; Piguet C; Bordigoni P; Michel G; Blanche S; Casanova JL; Thomas C; Vilmer E; Fischer A; Bertrand Y;
    Bone Marrow Transplant; 2003 Jun; 31(12):1097-103. PubMed ID: 12796789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning.
    Veys PA; Nanduri V; Baker KS; He W; Bandini G; Biondi A; Dalissier A; Davis JH; Eames GM; Egeler RM; Filipovich AH; Fischer A; Jürgens H; Krance R; Lanino E; Leung WH; Matthes S; Michel G; Orchard PJ; Pieczonka A; Ringdén O; Schlegel PG; Sirvent A; Vettenranta K; Eapen M
    Br J Haematol; 2015 Jun; 169(5):711-8. PubMed ID: 25817915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.
    Shimoni A; Hardan I; Ayuk F; Schilling G; Atanackovic D; Zeller W; Yerushalmi R; Zander AR; Kroger N; Nagler A
    Cancer; 2010 Aug; 116(15):3621-30. PubMed ID: 20564132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan.
    Morimoto A; Ishida Y; Suzuki N; Ohga S; Shioda Y; Okimoto Y; Kudo K; Ishii E;
    Pediatr Blood Cancer; 2010 Jan; 54(1):98-102. PubMed ID: 19728332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
    Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
    Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cell histiocytosis in children less than 2 years of age.
    Kusuma Kumary P; Priyakumari T; Chellam VG; James FV; Nair MK
    Indian Pediatr; 1999 Jan; 36(1):29-36. PubMed ID: 10709120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
    Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
    Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
    Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
    Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hungarian experience with Langerhans cell histiocytosis in childhood.
    Müller J; Garami M; Hauser P; Schuler D; Csóka M; Kovács G; Rényi I; Kovács G; Marosi A; Galántai I; Békési A; Kajtár P; Kiss CS; Nagy K; Bartyik K; Masáth P; Kriván G;
    Pediatr Hematol Oncol; 2006 Mar; 23(2):135-42. PubMed ID: 16651242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.